Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Korea.
BK21 Plus Biomedical Science Project, Seoul National University College of Medicine, Seoul, Korea.
J Korean Med Sci. 2020 Jul 13;35(27):e218. doi: 10.3346/jkms.2020.35.e218.
BACKGROUND: Human cytomegalovirus (HCMV) infection in glioblastoma multiforme (GBM) is associated with a poor prognosis and may affect the pathogenesis of GBM. In this study, we investigated the role of HCMV-infected astrocytoma cells in impairing the activity of cytotoxic T lymphocytes (CTLs) specific to the HCMV protein. METHODS: CTLs specific to HCMV immediate early (IE)-1 were expanded from peripheral blood mononuclear cells of healthy donors by stimulating CD8+ T lymphocytes with U373MG cells (ATCC HTB-17: male) expressing HCMV IE-1. The death rate of the target and the effector cells was determined by the total count of the remaining respective cells after the interaction of them. RESULTS: The death rate of the target cells by CTLs increased depending on HLA restriction and the effector:target (E:T) ratio. The death rate of effector cells in the HCMV-infected U373MG cell culture was 37.1% on day 4 post-infection. The removal of the culture supernatant from HCMV-infected U373MG cells prior to adding the effector cells increased target cell death from 8.4% to 40.8% at E:T = 1:1, but not at E:T = 3:1. The transfer of cells from a 24-hour co-culture of the HCMV-infected U373MG cells and CTLs to HCMV IE-1-expressing target cells resulted in decreasing the cell death rate of the target cells from 31.1% to 13.0% at E:T = 1:1, but not at E:T = 3:1. HCMV infection of U373MG cells decreases the activity of CTLs specific to HCMV when the number of CTLs is low. CONCLUSION: These results suggest that HCMV could impair CTL activity and facilitate glioblastoma growth unchecked by CTLs.
背景:人巨细胞病毒(HCMV)感染多形性胶质母细胞瘤(GBM)与预后不良相关,并且可能影响 GBM 的发病机制。在这项研究中,我们研究了 HCMV 感染的星形细胞瘤细胞在损害针对 HCMV 蛋白的细胞毒性 T 淋巴细胞(CTL)活性中的作用。
方法:通过用表达 HCMV IE-1 的 U373MG 细胞(ATCC HTB-17:雄性)刺激 CD8+T 淋巴细胞,从健康供体的外周血单核细胞中扩增针对 HCMV 立即早期(IE)-1 的 CTL。通过相互作用后各自剩余细胞的总数来确定靶细胞和效应细胞的死亡率。
结果:CTL 对靶细胞的死亡率取决于 HLA 限制和效应器:靶细胞(E:T)比。感染 HCMV 的 U373MG 细胞培养物中第四天的效应细胞死亡率为 37.1%。在添加效应细胞之前,从感染 HCMV 的 U373MG 细胞的培养上清液中去除细胞会使 E:T=1:1 时的靶细胞死亡率从 8.4%增加到 40.8%,但 E:T=3:1 时则不会。将感染 HCMV 的 U373MG 细胞与 CTL 进行 24 小时共培养的细胞转移到表达 HCMV IE-1 的靶细胞,可使 E:T=1:1 时的靶细胞死亡率从 31.1%降低至 13.0%,而 E:T=3:1 时则不会。当 CTL 数量较低时,HCMV 感染 U373MG 细胞会降低针对 HCMV 的 CTL 活性。
结论:这些结果表明,HCMV 可能会损害针对 HCMV 的 CTL 活性,并使 CTL 无法控制的胶质母细胞瘤不受抑制地生长。
Invest Ophthalmol Vis Sci. 2003-2
Cell Prolif. 2024-12
Virus Res. 2010-11-5
N Engl J Med. 2008-7-31